Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions

Pharmaceutical Development and Technology

Volumn 16, Issue 5, 2011, Pages 511-519

  Fox, Christopher B ^a   Lin, Susan ^a   Sivananthan, Sandra J ^a   Dutill, Timothy S ^a   Forseth, Kristen T ^a   Reed, Steven G ^a   Vedvick, Thomas S ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

Oil in water emulsion; Phosphatidylcholine; Squalene

Indexed keywords

EMULSIFYING AGENT; PHOSPHATIDYLCHOLINE; SQUALENE; WATER OIL CREAM;

ARTICLE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG CONCENTRATION; DRUG MANUFACTURE; DRUG STABILITY; EMULSION; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REPRODUCIBILITY; SHELF LIFE; ULTRACENTRIFUGATION; VISCOSITY; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; BIOLOGICAL ASSAY; DRUG DELIVERY SYSTEMS; EMULSIFYING AGENTS; EMULSIONS; HUMANS; OILS; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; REPRODUCIBILITY OF RESULTS; SQUALENE; VISCOSITY; WATER;

EID: 78650583468     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.495397     Document Type: Article

References (31)

1. Fox CB. Squalene emulsions for parenteral vaccine and drug delivery. Molecules 2009;14:3286-3312.
2. Yang YW, Wei AC, Shen SS. Te immunogenicity-enhancing efect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate-a revisit of the role of the hydrophile-lipophile balance (HLB) value. Vaccine 2005;23:2665-2675.
3. Washington C, Chawla A, Christy N, Davis SS. Te electrokinetic properties of phospholipid-stabilized fat emulsions. Int J Pharm 1989;54:191-197.
4. Schultze V, D'Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Safety of MF59 adjuvant. Vaccine 2008;26:3209-3222.
5. Chung H, Kim TW, Kwon M, Kwon IC, Jeong SY. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. J Control Rel 2001;71:339-350. (Pubitemid 32276053)
6. Anderson RC, Fox CB, Dutill TS, Shaverdian N, Evers TL, Poshusta GR, et al. Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations. Coll Surf B: Biointerfaces 2010;75:123-132.
7. Fox CB, Anderson RC, Dutill TS, Goto Y, Reed SG, Vedvick T. Monitoring the efects of component structure and source and formulation stability and adjuvant activity of oil-in-water emulsions. Coll Surf B: Biointerfaces 2008;65:98-105.
8. Takino T, Konishi K, Takakura Y, Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biol Pharm Bull 1994;17:121-125. (Pubitemid 24056997)
9. Hubbell JA, Tomas SN, Swartz MA. Materials engineering for immunomodulation. Nature 2009;462:449-460.
10. O'Hagan DT, Singh M. MF59: A safe and potent oil-in-water emulsion adjuvant. In: Singh M, editor. Vaccine adjuvants and delivery systems. Hoboken, NJ: John Wiley & Sons; 2007:115-129.
11. Muderhwa JM, Matyas GR, Spitler LE, Alving CR. Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery. J Pharm Sci 1999;88:1332-1339.
12. Norden TP, Siekmann B, Lundquist S, Malmsten M. Physicochemical characterisation of a drug-containing phos-pholipid-stabilised o/w emulsion for intravenous administration. Eur J Pharm Sci 2001;13:393-401. (Pubitemid 32618647)
13. Wang JJ, Sung KC, Hu OY, Yeh CH, Fang JY. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Rel 2006;115:140-149. (Pubitemid 44559707)
14. Mikrut B. Case study: Formulation of an intravenous fat emulsion. In: Burgess DJ, editor. Injectable dispersed systems: Formulation, processing, and performance. Boca Raton, FL: Taylor and Francis; 2005:415-425.
15. Benjamins JW, Turesson K, Nylander T. Formation of a liquid crystalline phase from phosphatidylcholine at the oil-aqueous interface. Langmuir 2005;21:2804-2810. (Pubitemid 40448942)
16. Yamamoto Y, Araki M. Efects of lecithin addition in oil or water phase on the stability of emulsions made with whey proteins. Biosci Biotech Biochem 1997;61:1791-1795. (Pubitemid 127471765)
17. Fang Y, Dalgleish DG. Casein adsorption on the surfaces of oil-in-water emulsions modifed by lecithin. Coll Surf B: Biointerfaces 1993;1:357-364.
18. Ishii F, Sasaki I, Ogata H. Efect of phospholipid emulsif-ers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions. J Pharm Pharmacol 1990;42:513-515. (Pubitemid 20301493)
19. Buszello K, Harnisch S, Muller RH, Muller BW. Te infuence of alkali fatty acids on the properties and the stability of parenteral o/w emulsions modifed with Solutol HS 15. Eur J Pharm Biopharm 2000;49:143-149. (Pubitemid 30126062)
20. Asai Y, Watanabe S. Interaction of ubiquinone-10 with dipalmi-toylphosphatidylcholine and their formation of small dispersed particles. Drug Dev Ind Pharm 2000;26:85-90. (Pubitemid 30075306)
21. Handa T, Saito H, Miyajima K. Phospholipid monolayers at the triolein-saline interface: Production of microemulsion particles and conversion of monolayers to bilayers. Biochemistry 1990;29:2884-2890. (Pubitemid 20122625)
22. Ishii F, Nagasaka Y. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections. Coll Surf B: Biointerfaces. 2004;37:43-47. (Pubitemid 39164192)
23. Lyons RT. Case study: Formulation development and scale-up production of an injectable perfuorocarbon emulsion. In: Burgess DJ, editor. Injectable dispersed systems: Formulation, processing, and performance. Boca Raton, FL: Taylor and Francis; 2005:371-392.
24. Olivecrona G, Olivecrona T. Clearance of artifcial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1998;1:143-151.
25. Vernooij EAAM, Kettens-van den Bosch JJ, Crommelin DJA. Rapid determination of acyl chain position in egg phosphati-dylcholine by high performance liquid chromatography/electrospray mass spectrometry. Rapid Comm Mass Spec 1998;12:83-86. (Pubitemid 28050424)
26. Wijesundera C. Te infuence of triacylglycerol structure on the oxidative stability of polyunsaturated oils. Lipid Technol 2008;20:199-202.
27. Ishii F, Nii T. Properties of various phospholipid mixtures as emulsifers or dispersing agents in nanoparticle drug carrier preparations. Coll Surf B: Biointerfaces 2005;41:257-262. (Pubitemid 40312742)
28. Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M. Adjuvant and haemolytic activities of 47 sapon-ins derived from medicinal and food plants. Biol Chem 2000;381:67-74. (Pubitemid 30102877)
29. Hjorth RN. Adjuvants for viral vaccines. US Patent 5,690,942. 1997.
30. Jumaa M, Kleinebudde P, Muller BW. Physicochemical properties and hemolytic efect of diferent lipid emulsion formulations using a mixture of emulsifers. Pharm Acta Helv 1999;73:293-301. (Pubitemid 29324994)
31. Yoon JK, Burgess DJ. Interfacial properties as stability predictors of lecithin-stabilized perfuorocarbon emulsions. Pharm Dev Tech 1996;1:333-341. (Pubitemid 28257336)